VRmagic’s new Fundoscopy Module can be mounted to the Eyesi Slit Lamp simulator table to enable a lifelike interaction. It is supported by comprehensive software offering a wide selection of cases for retinal examination, which will be continuously extended, according to a company news release.
Horizon Europe, the world’s largest multinational research and innovation programme, has issued its first call for grant applications.
Congratulations to Professor Andrew Dick for being reappointed as Director of UCL Institute of Ophthalmology for the next five years.
Aerie Pharmaceuticals announced the European Commission (EC) has granted a marketing authorization for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction of elevated IOP in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.
IoO's Dr Emily Patterson and UCL Slade School of Fine Art's Jo Guile were selected in the latest round of the Beacon Bursary public engagement funding scheme.
The International Council of Ophthalmology participated in the launch of a diabetic retinopathy screening guide developed by the WHO Regional Office for Europe.
The university professor will focus on pandemic recovery, supporting diversity in medicine
From humble beginnings as a small clinic with just 11 beds and the audacious goal of curing preventable blindness, the Aravind Eye Care System in southern India has grown into the largest eye care provider in the world and serves as a model for how cataract blindness might effectively be eliminated in the developing world.
José-Alain Sahel est intervenu lors du Téléthon 2020 pour évoquer les travaux de l’Institut sur les maladies rares de la Vision.
A drive-through intraocular pressure (IOP) screening clinic allows for continued management during the COVID-19 pandemic, according to a research letter published in JAMA Ophthalmology.
High-tech tools are increasingly being consolidated into specialized centres. Running these technological wonderlands takes a unique blend of skills.
A new global study has found no significant reduction in the number of people with treatable sight loss since 2010. Published in The Lancet Global Health, it examined population-based surveys of eye disease worldwide from 1980 and found public health services across the world are failing to meet targets to reduce avoidable sight loss.
2020 has been a year like no other. The COVID-19 pandemic pushed science to the forefront and dominated lives. But the year also produced fresh images unrelated to the virus.
RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health. Both companies have previously worked successfully on pilot projects in this disease area.
In light of the ongoing COVID-19 pandemic, the Glaucoma Research Foundation will host a virtual Glaucoma 360 annual meeting in 2021.